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Abstract
Leber’s hereditary optic neuropathy (LHON) is a maternally inherited blinding disease due to mitochondrial DNA (mtDNA)
point mutations in complex I subunit genes, whose incomplete penetrance has been attributed to both genetic and
environmental factors. Indeed, the mtDNA background defined as haplogroup J is known to increase the penetrance of the
11778/ND4 and 14484/ND6 mutations. Recently it was also documented that the professional exposure to n-hexane might
act as an exogenous trigger for LHON. Therefore, we here investigate the effect of the n-hexane neurotoxic metabolite 2,5-
hexanedione (2,5-HD) on cell viability and mitochondrial function of different cell models (cybrids and fibroblasts) carrying
the LHON mutations on different mtDNA haplogroups. The viability of control and LHON cybrids and fibroblasts, whose
mtDNAs were completely sequenced, was assessed using the MTT assay. Mitochondrial ATP synthesis rate driven by
complex I substrates was determined with the luciferine/luciferase method. Incubation with 2,5-HD caused the maximal loss
of viability in control and LHON cells. The toxic effect of this compound was similar in control cells irrespective of the mtDNA
background. On the contrary, sensitivity to 2,5-HD induced cell death was greatly increased in LHON cells carrying the
11778/ND4 or the 14484/ND6 mutation on haplogroup J, whereas the 11778/ND4 mutation in association with haplogroups
U and H significantly improved cell survival. The 11778/ND4 mutation on haplogroup U was also more resistant to inhibition
of complex I dependent ATP synthesis by 2,5-HD. In conclusion, this study shows that mtDNA haplogroups modulate the
response of LHON cells to 2,5-HD. In particular, haplogroup J makes cells more sensitive to its toxic effect. This is the first
evidence that an mtDNA background plays a role by interacting with an environmental factor and that 2,5-HD may be a risk
element for visual loss in LHON. This proof of principle has broad implications for other neurodegenerative disorders such as
Parkinson’s disease.
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Introduction
Leber’s hereditary optic neuropathy (LHON) is a maternally
inherited blinding disease due to three most frequent mitochon-
drial DNA (mtDNA) point mutations (11778/ND4, 3460/ND1
and 14484/ND6), which affect complex I subunit genes [1]. In
most LHON pedigrees the causative mtDNA mutation is
homoplasmic (100% mtDNA copies are mutant) in all maternally
related individuals, but only a subset of them develops the optic
neuropathy, usually estimated as about 50% of the males and 10%
of females [2]. The incomplete penetrance is assumed to depend
on further genetic and/or environmental factors, which may play
a role in triggering the visual loss and optic atrophy [3].
Among the genetic factors, there is now a solidly established
evidence that a Western Eurasian mtDNA background, known as
haplogroup J, plays a modifying role increasing the pathogenic
potential and hence the penetrance of the 11778/ND4 and
14484/ND6 LHON mutations [4,5]. The modifying effect of
haplogroup J is thought to be due to specific arrays of complex I
and III non-synonymous polymorphisms characterizing sub-
haplogroup J1 for the 14484/ND6 mutation and sublineages J1c
and J2b for the 11778/ND4 mutation [4]. The functional
alteration underlying this modifying effect has not been clearly
elucidated, but based on accumulation of non-synonymous
variants in complexes I and III, instability of supercomplexes has
been originally hypothesized [4,6]. However, recent studies
indicated an alternative mechanism to explain the association of
haplogroup J variants and LHON penetrance [7]. Furthermore,
there is experimental evidence that different mtDNA haplogroups
may maintain similar efficiencies of the respiratory function [8],
thanks to different settings of reactive oxygen species (ROS)
production and control of mitochondrial biogenesis [9]. Tran-
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influenced by specific variants in the D-loop region, again
involving haplogroup J [10]. The mtDNA background effect
seems to be only one of the possible modifying genetic factors, in
fact recent linkage analysis data suggest that one or more genes on
chromosome X may also affect LHON penetrance, possibly
explaining the male prevalence as well [11,12].
Environmental factors may also modulate LHON penetrance.
Until recently, most of the data presented in literature are still
scattered anecdotal reports. Tobacco smoking and alcohol
consumption have been proposed as possible triggers for LHON
[13–15], particularly because their combination has been
associated with a form of optic neuropathy, i.e. tobacco-alcohol
amblyopia [16], which in some cases was shown to be
misdiagnosed LHON [17]. However, a recent epidemiologic
study of a large cohort of LHON families reached a well-supported
conclusion that tobacco smoking is indeed a triggering factor [18].
In a similar manner, exposures to agricultural pesticides, smoke,
toxic vapours from industrial solvents have been variously
mentioned as possible environmental triggers for LHON
[15,19]. Recently, we also documented one case, a subject
carrying the 11778/ND4 mutation [20], for whom the combined
exposure to n-hexane and other solvents apparently acted as the
trigger for the optic neuropathy.
The association between occupational exposure to solvents and
neurological complications involving the retina and the optic nerve
is well established [21,22]. In a cross-sectional study on 15 workers
exposed to n-hexane, 11 showed macular changes and 1 had
central retinopathy [23]. Glue sniffers may also suffer optic
neuropathy and/or hearing loss [24–26]. Exposure to (or sniffing
of) toluene has been implicated in acute disturbances of color
vision and retinal and optic nerve degeneration [27,28].
Moreover, animal models of n-hexane exposure identified 2,5-
hexanedione (2,5-HD) as a neurotoxic n-hexane metabolite [29],
inducing deterioration in visual function [30]. Studies on n-hexane
toxicity showed uncoupling of mitochondrial respiration [31].
Furthermore, co-exposure and possible interactions between
solvents and/or their metabolites may synergize the potential
neurotoxicity accumulating in different tissues [32,33].
In the present study we have investigated the toxic effect of 2,5-
HD in cybrids and fibroblasts bearing LHON mutations and
evaluated the involvement of complex I. We also assessed whether
toluene further increases the 2,5-HD toxicity. Our results were
evaluated in relation to the sequence variation and the haplogroup
affiliation of the mtDNA on which the LHON pathogenic
mutation was present.
Results
Genetic Characterization of the Cells
We employed the well established cell model for mtDNA
functional studies called cybrids (transmitochondrial cytoplasmic
hybrids), which has the advantage to maintain a constant nuclear
background and use different mtDNAs [34]. However, nuclear
genome variation may also have specific interactions with the
mtDNA, thus primary cell lines derived from LHON patients,
such as fibroblasts, containing both the original nuclear and
mitochondrial genomes were also used.
Control and LHON cybrids are the same already characterized
in previous investigations, with all LHON cybrids being homo-
plasmic mutant for one of the three primary mutations [7,8,35–38].
For some of the cybrid clones the complete mtDNA sequence was
already available [7], but for the others has been determined in the
current study (Table 1).
The LHON fibroblasts were also homoplasmic mutant for one
of the three primary mutations. The complete mtDNA sequence
was also determined for both control and LHON fibroblasts
(Table 1). For each LHON and control cell line (cybrids and
fibroblasts), the haplogroup affiliation and the full list of non-
synonymous mtDNA mutations are listed in Table 1.
Viability Experiments with 2,5-HD in Cybrids
The 2,5-HD toxicity was analyzed by determining the dose-
response relationship in control (Figure 1A) and LHON cybrids
(Figure 1B). The loss of viability induced by 24 hours incubation
with different concentrations of 2,5-HD was independent of the
mtDNA background in control cybrids (Figure 1A). On the
contrary, LHON cybrids showed a mtDNA haplogroup depen-
dent behaviour (Figure 1B). The LHON cybrid clone carrying the
11778/ND4 mutation on haplogroup U was the most resistant to
the toxic effect of 2,5-HD (70% of cells still viable with 12 mg/ml),
whereas the LHON cybrid clones on haplogroup J1 were the most
sensitive (only 15% of cells viable). In particular, the LHON cybrid
clones carrying the 14484/ND6 mutation on haplogroup J1 (J1c
and J1b) were as sensitive to 2,5-HD as the one carrying the
11778/ND4 mutation on a similar background (J1c). LHON
cybrid clones bearing the 3460/ND1 mutation on haplogroups T
and H were similar to controls. The time-dependent changes of
viability in control and LHON cybrids, preincubated with 12 mg/
ml of 2,5-HD reported in figures 1C and 1D, showed a similar
behaviour. Figure 1E summarizes the percentages of viable cells
after 24 hours incubation with 12 mg/ml of 2,5-HD, showing that
the 11778/ND4 and 14484/ND6 LHON mutations in combina-
tion with haplogroup J1 were significantly more sensitive to the
toxic effect relative to controls. On the contrary, the cybrid clone
harbouring the 11778/ND4 mutation on haplogroup U was
significantly associated with a marked resistance to 2,5-HD
toxicity.
ATP Synthesis Rate in Cybrids Treated with 2,5-HD
We preliminarily attempted to measure the complex I activity in
cybrids to test if the toxic effect of 2,5-HD was mainly mediated
through this pathway, which is impaired by the LHON mutations.
However, we verified a low reproducibility of this assay, in
particular of the titration of 2,5-HD on complex I activity.
Alternatively, we decided to assess the ATP synthesis driven by
substrates of both complex I (pyruvate and malate) and complex II
(succinate) to investigate if and how the 2,5-HD toxic effect was
mediated by inhibition of the mitochondrial respiratory chain.
This analysis was restricted to the LHON cybrid clones that were
significantly different from controls in the viability assay as
reported in figure 1E.
Figures 2A and B show the 2,5-HD dose–response of ATP
synthesis driven by complex I and II substrates after addition of
2,5-HD to digitonized cybrids. 2,5-HD inhibited the rate of ATP
synthesis mediated by both the respiratory complexes, although its
effect was more relevant for complex I. In particular Figure 2A
illustrates that the inhibitory effect of 2,5-HD was maximal at the
concentration of 10 mg/ml for all cybrid clones, except for that
bearing the 11778/ND4 mutation on haplogroup U. The results
obtained at 10 mg/ml 2,5-HD are summarized in figures 2C and
D. The statistical analysis reveals that the ATP synthesis through
complex I in cybrids with the 11778/ND4 mutation on
haplogroup U only was significantly less sensitive to 2,5-HD
(Figure 2C). The same analysis carried out for complex II substrate
showed a similar inhibition of ATP synthesis in all cybrid clones
(Figure 2D), indicating that complex I might be seems specifically
affected by 2,5-HD.
mtDNA and 2,5-Hexanedione
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Cell lines GenBank ID LHON mutation Haplogroup Non-synonymous polymorphisms relative to CRS
a Amino acid change
Cybrids
HGA GQ304740 Control J1c T4216C (ND1)T y r .His
A10398G (ND3)T h r .Ala
A13681G (ND5)T h r .Ala
G13708A (ND5)A l a .Thr
C14766T (CYTB)T h r .Ile
T14798C (CYTB) Phe.Leu
C15452A (CYTB)L e u .Ile
HPC EU915472 [7] Control H5 A7245G (COI)T h r .Ala
HPS GQ304741 Control T2 T4216C (ND1)T y r .His
A4917G (ND2)A s n .Asp
C10750T (ND4L)A s n .Ser
C14766T (CYTB) Ile.Thr
C15452A (CYTB)L e u .Ile
HPE EU915476 [7] G11778A (ND4) J1c T4216C (ND1)T y r .His
A10398G (ND3)T h r .Ala
T12083G (ND4)S e r .Ala
G13708A (ND5)A l a .Thr
C14766T (CYTB)T h r .Ile
T14798C (CYTB) Phe.Leu
C15452A (CYTB)L e u .Ile
HFF EU915477 [7] G11778A (ND4) U5a1 G9477A (COIII)V a l .Ile
A9667G (COIII)A s n .Ser
C14766T (CYTB)T h r .Ile
A14793G (CYTB)H i s .Arg
RJ206 GQ304742 G3460A (ND1) T1a T4216C (ND1)T y r .His
A4917G (ND2)A s n .Asp
C14766T (CYTB)T h r .Ile
C15452A (CYTB)L e u .Ile
HMM12 EU915475 [7] G3460A (ND1) H12 A14552G (ND6)V a l .Ala
HL180 EU915479 [7] T14484C (ND6) J1c T4216C (ND1)T y r .His
T7042C (COI)V a l .Ala
A10398G (ND3)T h r .Ala
G13708A (ND5)A l a .Thr
G14279A (ND6)S e r .Leu
C14766T (CYTB)T h r .Ile
T14798C (CYTB) Phe.Leu
C15452A (CYTB)L e u .Ile
HBA2 EU915478 [7] T14484C (ND6) J1b T4216C (ND1)T y r .His
G5460A (ND2)A l a .Thr
G8557A (ATP6)A l a .Thr
A10398G (ND3)T h r .Ala
G13708A/(ND5) Ala.Thr
T13879C/(ND5) Ser.Pro
C14766T (CYTB)T h r .Ile
C15452A (CYTB)L e u .Ile
Fibroblasts
C88/F03W GQ304743 Control J1c T4216C (ND1)T y r .His
A10398G (ND3)T h r .Ala
mtDNA and 2,5-Hexanedione
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The cybrid cell model allows studying the effect of mtDNA
mutations in the context of the same nuclear background [34].
However, it has been reported that the cybridization process
causes a substantial cellular stress and that genetic instability could
produce variability in gene expression [39]. Furthermore, specific
variability in the interaction of nuclear and mitochondrial
genomes has been also reported and the coevolution of the two
genomes debated [40,41]. We therefore decided to test the effect
of 2,5-HD also in a set of control and LHON fibroblasts stratifying
again the results according to the haplogroup affiliation of their
mtDNAs.
Figure 3A shows that 24 hours incubation with different
concentrations of 2,5-HD reduced the viability of control
fibroblasts independently from the mtDNA background. On the
contrary, LHON fibroblasts carrying the 11778/ND4 mutation
on haplogroup H were the most resistant to the toxic effect of 2,5-
HD (at 12 mg/ml approximately 70% of cells still viable), whereas
the LHON fibroblasts on haplogroup J1 were the most sensitive
(Figure 3B). The behaviour of fibroblasts with the 14484/ND6
mutation bearing haplogroup V and with the 3460/ND1 mutation
on haplogroup U was similar to controls. The time-dependent
changes of viability in control and LHON fibroblasts treated with
12 mg/ml of 2,5-HD (figure 3C and 3D) reveals that, consistently
with the other experiments, the 11778/ND4 and 14484/ND6
mutations associated with haplogroup J1 were the most sensitive.
Furthermore, the 11778/ND4 mutation with haplogroup H and
the 14484/ND6 with haplogroup V were similarly resistant up to
16 hours incubation, whereas at 24 hours the viability of this latter
cell line decreased to values similar to controls. Figure 3E
Cell lines GenBank ID LHON mutation Haplogroup Non-synonymous polymorphisms relative to CRS
a Amino acid change
G13708A (ND5)A l a .Thr
C13934T (ND5)T h r .Met
C14766T (CYTB)T h r .Ile
T14798C (CYTB) Phe.Leu
C15452A (CYTB)L e u .Ile
KM/F08W GQ304744 Control T2b T4216C (ND1)T y r .His
A4917G (ND2)A s n .Asp
G9948A (COIII)V a l .Ile
T14766T (CYTB)T h r .Ile
C15452A (CYTB)L e u .Ile
VS/F07W GQ304745 Control H* none
FJ/F08L GQ304746 G11778A (ND4) J1c T4216C (ND1)T y r .His
G9145A (ATP6)A l a .Thr
A10398G (ND3)T h r .Ala
G13708A (ND5)A l a .Thr
A13933G (ND5)T h r .Ala
C14766T (CYTB)T h r .Ile
T14798C (CYTB) Phe.Leu
C15452A (CYTB)L e u .Ile
RA/F07L GQ304747 G11778A (ND4)H * A 7 9 0 4 G ( COII)T h r .Ala
G14249A (ND6)A l a .Val
CC/F09L EF060364 [44] G3460A (ND1) U4a C14766T (CYTB)T h r .Ile
T15693C (CYTB) Met.Thr
G15773A (CYTB)V a l .Met
WR/F30L GQ304748 T14484C (ND6) V none
HL/F29L
b EU915479 [7] T14484C (ND6) J1c T4216C (ND1)T y r .His
T7042C (COI)V a l .Ala
A10398G (ND3)T h r .Ala
G13708A (ND5)A l a .Thr
G14279A (ND6)S e r .Leu
C14766T (CYTB)T h r .Ile
T14798C (CYTB) Phe.Leu
C15452A (CYTB)L e u .Ile
arCRS refers to the revised Cambridge reference sequence [58]. In addition, all mtDNAs differed from rCRS, which belongs to haplogroup H2a, for A8860G (ATP6)a n d
A15326G (CYTB).
bThis fibroblast cell line is from the same patient and harbours the same mtDNA as cybrid HL180.
doi:10.1371/journal.pone.0007922.t001
Table 1. Cont.
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12 mg/ml of 2,5-HD, showing that a similar decrease in viable
cells (about 50%) was observed in control fibroblasts with
haplogroups J1, T, and H. Conversely, LHON fibroblasts carrying
the 11778/ND4 or 14484/ND6 mutations in association with
haplogroup J1 were again significantly more sensitive to the toxic
effect of 2,5-HD. Interestingly, LHON fibroblasts with the 11778/
ND4 mutation on a haplogroup H background were markedly
more resistant to the toxicity of this compound, whereas no
differences were observed with the other mutation/haplogroup
combinations relative to controls.
Viability Experiments with Combined 2,5-HD and Toluene
We further evaluated whether cells were differently affected by
thesimultaneous incubation with2,5-HDand toluene,based onour
previous reporton a LHON patientwho developed the disease after
exposure to a combination of different organic solvents [20]. To this
end a preliminary experiment was carried out by the head-space/
Figure 1. Effect of 2,5-HD on viability of control and LHON cybrids with mtDNAs belonging to different haplogroups. Dose-responses
of viability of control (A) and LHON (B) cybrids, with the respective mtDNA haplogroups, incubated for 24 hours in DMEM containing the indicated
amounts of 2,5-HD. Time-courses of viability of control (C) and LHON (D) cybrids incubated with 12 mg/ml 2,5-HD. (E) Statistical analysis of the same
data obtained in control and LHON cybrids, incubated for 24 hours with 12 mg/ml 2,5-HD. Cell viability was determined and statistically analyzed as
described in the Methods section. Data are means6SD of at least 3 determinations. *denotes significantly different values (p,0.05) determined by
One Way ANOVA followed by the Holm-Sidak method.
doi:10.1371/journal.pone.0007922.g001
mtDNA and 2,5-Hexanedione
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toluene soluble in DMEM, with and without 2,5-HD. We
established that the maximum concentration of toluene soluble in
DMEM was 0.5 mg/ml, which increased to 0.6 mg/ml in the
presence of 2,5-HD (data not shown). Cell viability was than
evaluated after 24 hours incubation with both 2,5-HD (12 mg/ml)
and toluene (0.6 mg/ml). Figure 4A shows that the final mixture
caused a marked decrease of viability in all cybrids, except in those
bearing the 11778/ND4 or 14484/ND6 mutations with hap-
logroup J1c. For the control cybrid clone with haplogroup H and
the LHON 3460/ND1 cybrid clone on haplogroup T, only a non-
significant tendency was observed for the additive effect of toluene.
A similar additive effect was also observed in fibroblasts (Figure 4B),
except for the 3460/ND1 mutation on haplogroup U and again the
11778/ND4 or 14484/ND6 mutations with haplogroup J1c. It is
worth noting that exposure to toluene alone had no effect on cell
viability (data not shown).
Discussion
The current study shows that mtDNA genetic variation, defined
in terms of haplogroups, and environmental factors may interact
becoming relevant to the pathogenesis of a human disease. The
proof of principle of this interaction has broad implications on
disease predisposition. In the specific case we applied the paradigm
of a mitochondrial disorder dependent on mtDNA point mutations,
for which there was an established evidence that certain mtDNA
backgrounds play a role to modulate penetrance [4,5]. Our results
have a two-fold relevance for LHON patients. First, 2,5-HD has a
detrimental effect on cell viability. Second, the sensitivity to this
toxicant of cells carrying the 11778/ND4 and 14484/ND6 LHON
pathogenicmutationsismodified bythemtDNAbackground,being
haplogroup J1 the most sensitive. Haplogroup J is also the same
mtDNA background previously associated with an increased
penetrance for these LHON mutations [4,5].
By studying cells under the assumption of a constant nuclear
background, in which different mtDNAs were introduced, we
observed that haplogroup J1 was the most sensitive to the toxicant,
when the LHON pathogenic mutations 11778/ND4 or 14484/
ND6 were present. Only the combination of these LHON
pathogenic mutations with haplogroup J1 background increased
the sensitivity to 2,5-HD, as shown by the direct comparison with
control cybrids carrying haplogroup J1 mtDNA without the LHON
mutations. Moreover, we observed that the single cybrid clone
carrying the 11778/ND4 mutation on haplogroup U behaved as
the most resistant to the toxicant effects. Unfortunately, we could
not mirror our results on haplogroup J1 for the LHON cell line
carrying haplogroup U, not having available a control cybrid cell
line with a haplogroup U mtDNA for direct comparison.
Figure 2. Effect of 2,5-HD on ATP synthesis of control and LHON cybrids with mtDNAs belonging to different haplogroups. Dose-
responses of ATP synthesis rate driven by complex I substrates (A) and complex II substrate (B) in digitonin-permeabilized cybrids after addition of the
indicated amounts of 2,5-HD. Data are expressed as percentage of the values obtained in untreated samples. Statistical analysis of the same data of
ATP synthesis rate obtained in control and LHON cybrids incubated with 10 mg/ml 2,5-HD in the presence of complex I substrates (C) or complex II
substrate (D). Data are means6SD of at least 3 determinations. *denotes significantly different values (p,0.05), determined by One Way ANOVA
followed by the Holm-Sidak method.
doi:10.1371/journal.pone.0007922.g002
mtDNA and 2,5-Hexanedione
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e7922By direct assessment of the ATP synthesis rate, we also
demonstrated that the neurotoxin 2,5-HD inhibited the oxidative
phosphorylation. Previous studies documented a direct effect of
the n-hexane metabolite 2,5-HD at the mitochondrial level. In
fact, inhibition of state 3 respiration was reported after 2,5-HD
addition to isolated brain mitochondria and also after chronic
treatment of rats [42]. Furthermore, 2,5-HD was shown to induce
apoptotic death in spermatogenic cells through a mitochondrial
pathway, involving loss of mitochondrial membrane potential
[43]. We report here that the 2,5-HD effect was more relevant in
the presence of the complex I substrates, having observed that the
LHON cybrid cell line carrying haplogroup U was still the most
resistant, whereas no difference between cybrid cell lines was
observed with the complex II substrate succinate. One conclusion
that we can draw from this first round of experiments is that only
the co-presence of the mtDNA pathogenic mutation for LHON
Figure 3. Effect of 2,5-HD on viability of control and LHON fibroblasts with mtDNAs belonging to different haplogroups. Dose-
responses of viability of control (A) and LHON (B) fibroblasts, with the respective mtDNA haplogroups, incubated for 24 hours in DMEM containing
the indicated amounts of 2,5-HD. Time-courses of viability of control (C) and LHON (D) fibroblasts incubated with 12 mg/ml 2,5-HD. (E) Statistical
analysis of the same data obtained in control and LHON fibroblasts, incubated for 24 hours with 12 mg/ml 2,5-HD. Cell viability was determined and
statistically analyzed as described in the Methods section. Data are means6SD of 3 determinations. *denotes significantly different values (p,0.05),
determined by One Way ANOVA followed by the Holm-Sidak method.
doi:10.1371/journal.pone.0007922.g003
mtDNA and 2,5-Hexanedione
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modifying role. In other words, the co-occurrence of the primary
LHON mutations 11778/ND4 and 14484/ND6 with the
haplogroup J1 background further enhances cybrid sensitivity to
the neurotoxin 2,5-HD.
To confirm these results on the cybrid cell system, we run the
same experiments on fibroblasts obtained from controls and
LHON patients. Despite the variable nuclear background, we
observed the same specific hypersensitivity to 2,5-HD toxicity
with the LHON/haplogroup J1 fibroblasts (11778/ND4 and
14484/ND6 mutations). It is worthy of note that in this case the
direct comparison of two LHON cases carrying both the 14484/
ND6 mutation, one on haplogroup V and one on haplogroup J1,
showed that only the combination 14484/J is hypersensitive to the
toxicant. It is of further note that the fibroblasts with the 11778/
ND4 mutation on haplogroup H mtDNA showed high resistance
to the toxic effect of 2,5-HD. The fact that two unrelated cases
with the 11778/ND4 mutation (the cybrid with a haplogroup U
mtDNA and the fibroblasts with a haplogroup H mtDNA) were
both hyper-resistant to the toxicant prompts the speculation that
the 11778/ND4 mutation itself confers this resistance, whereas its
combination with haplogroup J1 confers hyper-sensitivity.
Further support to this hypothesis derives by the direct
comparison of the LHON fibroblasts carrying the 11778/ND4
mutation on a haplogroup H mtDNA with the companion control
fibroblasts with a mtDNA belonging to the same haplogroup, the
latter failing to show any resistance to 2,5-HD toxicity. On the
other hand also the 3460/ND1 mutation on haplogroups H
(cybrids) and U (fibroblasts) did not show differences in 2,5-
HD sensitivity relative to controls, thus supporting our hypoth-
esis of a direct role for the 11778/ND4 mutation in 2,5-HD
resistance.
The functional consequences of the non-synonymous variants
clustered on haplogroup J, involving both complex I ND subunit
genes and cytochrome b (cyt b), the only mtDNA-encoded subunit of
complex III, remain poorly understood. Haplogroups J and T
share a common root characterized by the 4216/ND1 and 15452/
cyt b ancient polymorphisms [4,44]. Haplogroups J and T then
diverged by acquiring the 13708/ND5+10398/ND3 and the
4917/ND2 polymorphisms, respectively [4,44]. Therefore, the
13708/ND5 as well as the 10398/ND3 variants are still ancient
root mutations, predating the divergence of haplogroup J into
subclades. Some of these clades, J1c and J2b in particular, which
have accumulated additional and more recent non-synonymous
nucleotide changes (14798/cyt b for J1c and 15257/cyt b+15812/cy
tb for J2b), have been associated with an increased penetrance of
the 11778/ND4 and 14484/ND6 mutations [4,5,7]. The specific
role played by all these different ND+cyt b variants clustered in J1c
and J2b subclades of haplogroup J needs to be properly
investigated [4,7]. However, there is also a deeper level of
molecular complexity that needs to be considered. This is
constituted by other non-synonymous changes, often defined as
‘‘private’’ or ‘‘almost private’’ mutations, which because of their
very low population frequencies are not (yet) reported in any of the
currently available databases for mtDNA variation, and for which
a functional role in some cases is not unlikely. The sequencing of
the entire mitochondrial genome allowed us to identify all non-
synonymous changes in our cell lines (Table 1). We found out, for
instance, that the HL/F29L fibroblasts and the relate cybrid
HL180 carry the 7042T.C/COI and the 14279G.A/ND6
mutations together with the 14484/ND6 canonical LHON
mutation [7]. Similarly the 9145G.A/ATP6 non-synonymous
change is present in the FJ/F08L fibroblasts and the combination
of 7904A.G/COII+14249G.A/ND6 changes characterizes the
RA/F07L fibroblasts. At the moment, it is not possible to predict
the effect, if any, for these non-synonymous variants, especially
taking into account that their specific effects could be modulated
by the mtDNA background. However, one noticeable feature that
is evident from Table 1 is that all cells carrying a haplogroup J
mtDNA harbor an extensive accumulation of non-synonymous
variants. This finding may explain the special behaviour of
haplogroup J in modulating the 2,5-HD toxicity, as shown by the
current study, and in influencing LHON penetrance as previously
reported [4,5].
In both cell systems, cybrids and fibroblasts, we also tested the
combined effect of two toxicants, adding toluene to 2,5-HD, as we
recently documented that humans may suffer exposure to a
mixture of solvents [20]. In this case the synergic action of the two
toxicants was demonstrated in most cell lines (cybrids and
fibroblasts), but doing so we minimized most of the differences
due to the mtDNA background. In particular, it must be noticed
that all the LHON cell lines on the haplogroup J1c were already
Figure 4. Viability of control and LHON cells after incubation
with 2,5-HD and toluene. Cybrids (A) and fibroblasts (B) were
incubated for 24 hours in DMEM containing 12 mg/ml 2,5-HD alone or
in the presence of 5 mg/ml toluene. Cell viability was determined as
described in figure 1. Data are means6SD of 5 determinations.
*denotes significantly different values (p,0.05) between cells treated
with 2,5-HD alone or in the presence of toluene, using the Student’s t
test.
doi:10.1371/journal.pone.0007922.g004
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change their viability, whereas all control cells with haplogroup
J1c did show a further, significant depression of their viability. By
experimenting different conditions, we have noted that the
interaction of toluene with 2,5-HD was essentially based on the
fact that 2,5-HD increases the solubility of toluene in the medium
compared to the addition of toluene alone. The synergic effect of
the co-exposure to both toxicants becomes particularly relevant
when we consider those cells carrying the 11778/ND4 mutation
on haplogroups U or H, which were resistant to 2,5-HD alone, but
decreased their viability as those with haplogroup J1c after adding
toluene (Figure 4). This applies directly to the LHON patient we
previously reported, which carried the 11778/ND4 mutation on a
haplogroup H and was exposed at least to both n-hexane and
toluene [20].
The results of the present in vitro study, which was designed only
for a ‘‘proof of principle’’ demonstration, not necessarily can be
directly translated into the effects of real-life exposure to 2,5-HD in
human subjects genetically predisposed to LHON (or to other
mitochondrial diseases). The absence of an animal model for
LHON greatly limits more extensive investigations. However, it
should be noticed that the concentrations of 2,5-HD used in the
present study were much higher than would be encountered in
real-world situations, such as those where occupational exposure
to n-hexane metabolite (of which the 2,5-HD is the toxic
metabolite) can lead to neuropathy [45]. However, it is also
unknown how these toxicants may be absorbed, transported and
accumulated both in cultured cells(cybrids and fibroblasts) or in vivo
tissues and in particular, the concentrations achieved in mito-
chondria of retinal ganglion cells in the retina. Moreover, the limit
values proposed for the occupational oxposure to n-hexane are
calculated on the basis of is capability to produce, through 2,5-
HD, axonal damages but nothing is known about the exposure
level can lead to death of fibroblasts or other cells.
The proof of principle provided by the present study,
demonstrating that mtDNA haplogroups may interact with
environmental factors, has broad implications. For example,
exposure to environmental factors, either toxic as tobacco smoke
or the complex I inhibitor rotenone widely used as pesticide, or
even just variations in diet, have all been variously implicated in
predisposition to cancer or late onset neurodegenerative diseases
such as Parkinson (PD) and Alzheimer (AD) diseases [46]. In the
case of PD there are multiple analogies with LHON. For PD there
is converging evidence that defective complex I underlies part of
the pathogenic mechanism. In fact, it has been experimentally
shown that 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP)
and rotenone exposure, both complex I inhibitors, may induce a
disorder closely mimicking PD in humans and animals [47–50].
Based on this evidence, it has been proposed that the wide use of
rotenone as pesticide and its environmental presence may underlie
a subset of the sporadic PD cases in the US [50]. Furthermore,
certain single nucleotide polymorphisms or a haplogroup have
been suggested to play a modifying role [51,52]. These
considerations put Parkinson disease on the spot for being another
candidate disease to investigate the possible interaction of
environmental exposure to toxics and mtDNA haplogroups in
modulating protection or predisposition to develop the disease.
Similar scenarios may be envisaged for mtDNA haplogroup/diet
interactions in high impact diseases such as hypertension, obesity,
diabetes and cancer [53]. Careful evaluations performed by
combining large scale epidemiological investigation with in vitro cell
studies may prove a powerful tool to highlight specific genetic/
environmental interactions relevant for the pathogenic or
protective mechanisms in these very frequent disorders.
Materials and Methods
Materials
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide
(MTT), oligomycin, rotenone, pyruvate, malate, succinate, ATP
monitoring kit, toluene and 2,5HD were purchased from Sigma-
Aldrich (Milan, Italy).
Sequence Variation of mtDNAs and Haplogroup
Affiliation
The three LHON mtDNA pathogenic mutations (11778/ND4,
3460/ND1 and 14484/ND6) were screened in LHON cybrids
and fibroblasts by standard PCR amplification of convenient
mtDNA fragments followed by digestion with appropriate
restriction enzymes [44].
The mtDNA sequence variation and haplogroup affiliation of
cybrids and fibroblasts, except those already characterized [7,54],
was determined by sequencing their entire mitochondrial genome
as previously reported [4].
Cells and Culture Condition
Transmitochondrial cytoplasmic hybrids (cybrids) were gener-
ated as previously reported from control donor and LHON
fibroblasts [34]. Cybrids were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal calf serum
(South America source from Gibco, Invitrogen, Italy), 2 mM L-
glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and
0.1 mg/ml bromodeoxyuridine, in an incubator with a humidified
atmosphere of 5% CO2 at 37uC. Skin fibroblasts were derived,
following informed consent, from three healthy donors and six
LHON patients from unrelated families bearing the 11778/ND4,
3460/ND1 and 14484/ND6 mutations. Fibroblasts were grown in
DMEM supplemented with 10% fetal bovine serum, 2 mM L-
glutamine and antibiotics. For the experiments, 4610
4 cells were
seeded in 24-well dishes and incubated for 24 hours with 2,5-HD
alone, or after toluene addition.
Cell Viability Measurement
The percentage of viable cells was measured with the
colorimetric 3-(4,5-dimethyl thiazol-2yl)-2,5-diphenyl tetrazolium
bromide (MTT) assay, as previously described [35]. Briefly, after
24 hours incubation with different amount of 2,5-HD, 0.5 mg/ml
MTT was added to the medium and after 3 hours, 5% SDS and
5 mM HCl were added to solubilize the formazan salt crystals.
Absorbance was measured using a VICTOR3 Multilabel Plate
Counter (PerkinElmer Life and Analytical Sciences, Zaventem
Belgium) with a 570 nm filter.
ATP Synthesis Assay and Inhibition by 2,5-HD
The assay of mitochondrial ATP synthesis was performed
according to Manfredi et al. [55], with minor modifications.
Briefly, after trypsinization, cells (10610
6/ml) were resuspended in
buffer A (10 mM KCl, 25 mM Tris-HCl, 2 mM EDTA, 0.1%
BSA, 10 mM potassium-phosphate, 0.1 mM MgCl2, pH 7.4), kept
for 15 min at room temperature, and then incubated with 50 mg/
ml digitonin for 1 min. After centrifugation, the cell pellet was
resuspended in buffer A and aliquots were taken to measure ATP
synthesis, protein content [56] and citrate synthase activity [57].
Aliquots of cells (0.1–0.2 mg protein) were incubated with 5 mM
malate plus 5 mM glutamate (complex I substrates) or with
10 mM succinate plus 2 mg/ml rotenone (complex II substrate) in
the presence or absence of 10 mg/ml 2,5-HD. The reaction was
started by addition of 0.2 mM ADP in the presence of luciferine/
mtDNA and 2,5-Hexanedione
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chemiluminescence was determined as a function of time with a
luminometer. After addition of 10 mM oligomycin, the chemilu-
minescence signal was calibrated with an internal ATP standard.
The residual activity of ATP synthesis after addition of 2,5-HD
was expressed as percentage of the activity of untreated cells.
Statistical Analysis
Data, expressed as means of at least three determinations6SD,
were analyzed using One Way ANOVA followed by the Holm-
Sidak method. Values for each LHON cybrid cell line were
analysed versus grouped values of all control cybrids using the
Student’s t test. P values,0.05 were considered significant.
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